BIS ETF: ProShares UltraShort Nasdaq Biotechnology - Price, Holdings & Analysis
ProShares UltraShort Nasdaq Biotechnology Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About ProShares UltraShort Nasdaq Biotechnology
What is the current price of BIS?
The latest BIS price is $10.97. The 52-week range is $8.30–$20.00. BIS has returned -18.5% over the past 52 weeks.
What is the expense ratio for BIS?
BIS's annual expense ratio is 0.95%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does BIS pay dividends?
Yes, BIS pays a 10.38% dividend yield. The last ex-dividend date was 2026-09-30. View full dividend history in the Dividends section.
What are the top holdings of BIS?
BIS's largest holdings are Amgen Inc (8.1%), Gilead Sciences, Inc (7.4%), Vertex Pharmaceuticals Incorporated (7.2%) (combined weight: 22.8%). The fund holds 6 total positions. View the complete portfolio breakdown in the Holdings section.
How does BIS compare to similar ETFs?
Compare BIS (0.95% expense ratio, $2M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.